| 000 | 01844 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517034420.0 | ||
| 264 | 0 | _c20160308 | |
| 008 | 201603s 0 0 eng d | ||
| 022 | _a1936-2625 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aXu, Ping | |
| 245 | 0 | 0 |
_ashRNA-mediated silencing of sorcin increases drug chemosensitivity in myeloma KM3/DDP and U266/ADM cell lines. _h[electronic resource] |
| 260 |
_bInternational journal of clinical and experimental pathology _c2015 |
||
| 300 |
_a2300-10 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B _xgenetics |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aApoptosis Regulatory Proteins _xmetabolism |
| 650 | 0 | 4 |
_aBreast Neoplasms _xchemistry |
| 650 | 0 | 4 |
_aCalcium-Binding Proteins _xgenetics |
| 650 | 0 | 4 |
_aCell Cycle Checkpoints _xdrug effects |
| 650 | 0 | 4 |
_aCell Cycle Proteins _xmetabolism |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aCisplatin _xpharmacology |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aDoxorubicin _xpharmacology |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xgenetics |
| 650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
| 650 | 0 | 4 |
_aGlioma _xchemistry |
| 650 | 0 | 4 | _aHep G2 Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMultidrug Resistance-Associated Proteins _xgenetics |
| 650 | 0 | 4 |
_aMultiple Myeloma _xdrug therapy |
| 650 | 0 | 4 | _aRNA Interference |
| 650 | 0 | 4 |
_aRNA, Small Interfering _xgenetics |
| 650 | 0 | 4 |
_aRhodamine 123 _xmetabolism |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 | _aTransfection |
| 700 | 1 | _aJiang, Yong-Fang | |
| 700 | 1 | _aWang, Jing-Hua | |
| 773 | 0 |
_tInternational journal of clinical and experimental pathology _gvol. 8 _gno. 3 _gp. 2300-10 |
|
| 999 |
_c24954097 _d24954097 |
||